Federal Register / Vol. 87, No. 74 / Monday, April 18, 2022 / Notices 22889 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–22–0338] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Annual 

Submission of the Ingredients Added to, 

and the Quantity of Nicotine Contained 

in, Smokeless Tobacco Manufactured, 

Imported, or Packaged in the U.S.’’ to 

the Office of Management and Budget 

(OMB) for review and approval. CDC 

previously published a ‘‘Proposed Data 

Collection Submitted for Public 

Comment and Recommendations’’ 

notice on September 27, 2021, to obtain 

comments from the public and affected 

entities. CDC did not receive comments 

related to the FRN. This notice serves to 

allow an additional 30 days for public 

and affected entities’ comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary for the 

proper performance of the functions of the 

agency, including whether the information 

will have practical utility; 

(b) Evaluate the accuracy of the agencies 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and assumptions 

used; 

(c) Enhance the quality, utility, and clarity 

of the information to be collected; 

(d) Minimize the burden of the collection 

of information on those who are to respond, 

including, through the use of appropriate 

automated, electronic, mechanical, or other 

technological collection techniques or other 

forms of information technology, e.g., 

permitting electronic submission of 

responses; and 

(e) Assess information collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

Annual Submission of the Ingredients 

Added to, and the Quantity of Nicotine 

Contained in, Smokeless Tobacco 

Manufactured, Imported, or Packaged in 

the U.S. (OMB Control No. 0920–0338, 

Exp. 04/30/2022)—Extension—National 

Center for Chronic Disease Prevention 

and Health Promotion (NCCDPHP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

Smokeless tobacco products (SLT) are 

associated with many health problems. 

Using smokeless tobacco can lead to 

nicotine addiction; causes cancer of the 

mouth, esophagus, and pancreas; is 

associated with diseases of the mouth; 

can increase risks for early delivery and 

stillbirth when used during pregnancy; 

can cause nicotine poisoning in 

children; and may increase the risk for 

death from heart disease and stroke. 

The CDC’s Office on Smoking and 

Health (OSH) has the primary 

responsibility for the HHS smoking and 

health program. As required by the 

Comprehensive Smokeless Tobacco 

Health Education Act of 1986 (CSTHEA, 

15 U.S.C. 4401 et seq., Pub. L. 99–252), 

CDC collects a list of ingredients added 

to tobacco in the manufacture of 

smokeless tobacco products and a 

specification of the quantity of nicotine 

contained in each product. HHS has 

delegated responsibility for 

implementing the required information 

collection to CDC’s Office of Smoking 

and Health (OSH). Respondents are the 

manufacturers, packagers, or importers 

(or their representatives) of smokeless 

tobacco products. Respondents are not 

required to submit specific forms; 

however, they are required to meet 

reporting guidelines and to submit the 

ingredient and nicotine reports. 

Ingredient reports must be submitted by 

chemical name and Chemical Abstract 

Service (CAS) Registration Number, 

consistent with accepted reporting 

practices for other companies that are 

required to report ingredients added to 

other consumer products. Typically, 

respondents submit a summary report to 

CDC with the ingredient information for 

multiple products, or a statement that 

there are no changes to their previously 

submitted ingredient report. 

Respondents may submit the required 

information to CDC through a 

designated representative. The 

information collection is subject to strict 

confidentiality provisions. 

Ingredient and nicotine reports for 

new SLT products are due at the time 

of first importation. Thereafter, 

ingredient and nicotine reports are due 

annually on March 31. Information is 

submitted to CDC by mailing a written 

report on the respondent’s letterhead. 

Electronic mail submissions are not 

accepted. Annual submission reports 

are mailed to Attention: FCLAA 

Program Manager, Office on Smoking 

and Health, National Center for Chronic 

Disease Prevention and Health 

Promotion, Centers for Disease Control 

and Prevention, 4770 Buford Highway, 

NE, MS S107–7, Atlanta, GA 30341– 

3717. 

Upon receipt and verification of the 

annual nicotine and ingredient report, 

CDC issues a Certificate of Compliance 

to the respondent. As deemed 

appropriate by the Secretary of HHS, 

HHS is authorized to use the 

information to report to Congress the 

health effects of ingredients, research 

activities related to the health effects of 

ingredients, and other information that 

the Secretary determines to be of public 

interest. 

OMB approval is requested for three 

years. CDC requests OMB approval for 

an estimated 18,843 annual burden 

hours. There are no costs to respondents 

other than their time to participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Smokeless Tobacco Manufacturers, Packagers, and Importers.SLT Ingredient Report ............ 11 1 6.5 


khammond on DSKJM1Z7X2PROD with NOTICES
22890 Federal Register / Vol. 87, No. 74 / Monday, April 18, 2022 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Smokeless Tobacco Manufacturers, Packagers, and Importers.SLT Nicotine Report ............... 11 1 1,706.5 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–08214 Filed 4–15–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–22–1128; Docket No. CDC–2022– 

0050] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled State 

Unintentional Drug Overdose Reporting 

System (SUDORS). This information 

collection supports drug overdose 

prevention efforts, detects new trends in 

fatal unintentional drug overdoses, and 

assesses the progress of HHS’s initiative 

to reduce opioid abuse. 

DATES: CDC must receive written 

comments on or before June 17, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0050 by either of the following methods: 

• Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7570; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

State Unintentional Drug Overdose 

Reporting System (SUDORS) (OMB 

Control No. 0920–1128, Exp. 10/31/ 

2023)—Revision—National Center for 

Injury Prevention and Control (NCIPC), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

This is a Revision request for the 

currently approved State Unintentional 

Drug Overdose Reporting System 

(SUDORS) (OMB Control No. 0920– 

1128, Exp. Date 10/31/2023). SUDORS 

assists with ongoing surveillance of fatal 

unintentional and undetermined intent 

drug-related overdoses to support 

prevention and response efforts. 

In 2013, there were nearly 44,000 

drug overdose deaths, including nearly 

36,000 unintentional drug overdose 

deaths, in the United States, with more 

people now dying of drug overdoses 

than automobile crashes. A major driver 

of the problem are overdoses related to 

opioids, both opioid pain relievers 

(OPRs) and illicit forms such as heroin. 

In order to address this public health 

problem, the U.S. Department of Health 

and Human Services (HHS) has made 

addressing the opioid abuse problem a 

high priority. 

To support targeting of drug overdose 

prevention efforts, detect new trends in 

fatal unintentional drug overdoses, and 

assess the progress of HHS’s initiative to 

reduce opioid abuse and overdoses, the 

State Unintentional Drug Overdose 

Reporting System (SUDORS) generates 

public health surveillance information 

at the national, state, and local levels. 

This information is more detailed, 

useful, and timely than other 

information that is currently available. 

This collection will detect state and 

local community changes in 

unintentional and undetermined intent 

drug-related overdose mortality faster 

and provide in-depth state and local 

(e.g., county) information on risk factors 

for fatal drug overdose deaths that can 


khammond on DSKJM1Z7X2PROD with NOTICES